26 - Drug interactions Flashcards

1
Q

Erythromycin

A

INHIBITOR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ketoconazole

A

INHIBITOR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Phenytoin

A

Enzyme INDUCER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Carbamezepine

A

Enzyme INDUCER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Grapefruit Juice

A

INHIBITOR

of cyp3a4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ciprofloxacin

A

INHIBITOR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Amiodarone

A

Enzyme INHIBITOR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Fluoxetine

Norfluoxetine

A

INHIBITOR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cimetidine

A

INHIBITOR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Rifampin

A

Enzyme INDUCER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

St. John’s Wort

A

Enzyme INDUCER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Object Drug

A

Drug that is AFFECTED by the interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Precipitant Drug

A

Drug that is CAUSING the interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Narrow Therapeutic Index

NTI

A

Effective Dose - Toxic dose = SMALL

small gap between ED & LD

  • Anticoags
  • Anti diabetics
  • Digoxin / benzo
  • Immunosuppresant / cytotoxic drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

3 Different Mechanisms of Drug Interactions

A

pharmaCEUTICAL

pharmaCOKINETIC

pharmaCODYNAMIC

17
Q

PharmaCEUTICAL Interactions

A

AKA Incompatability

Occurs BEFORE drug is administered to patient

  • Drugs given by IV
    • haziness / color change / particulates
  • Phenytoin + Dextrose = crystalization
  • Ampacillin / chlorpromazine / barbs
    • –> interact w/ dextran solution
18
Q

PharmacoKINETIC interactions

A

ADME Interactions

Altered PLASMA CONCENTRATION of drug

  • ADME interactions
19
Q

Absorption

PharmacoKINETIC Interactions

A

Faster / Slower Absorption

More / Less complete interaction

  • Complexation
  • Alter of pH
  • Gut motility
  • Inhibition of GI enzymes
  • Gi microflora
  • MALABSORPTION Syndrome
20
Q

Metabolism

PharmacoKINETIC Interactions

A

Metabolism of Object Drug is Aletered

  • Enzyme INDUCTION
    • ​–> Increased metabolism
  • ​Enzyme INHIBITION
    • –> decreased metabolism
      • –> MOST SIGNIFICANT INTERACTIONS
        • ​–> TOXICITY CAN BE FATAL
21
Q

Prodrugs

PharmacoKINETIC Interactions

A

Produce the OPPOSITE

Drug needs metabolism –> to be ACTIVE

codeine / clopidogrel

22
Q

Excretion

PharmacoKINETIC Interactions

A

Excretion pattern of object drug is altered

  • Alteration in RENAL BLOOD FLOW
    • ​AntiHypertensives / NSAIDS
  • urine pH
  • Competition for active secretion
  • Forced diuresis
23
Q

Antihypertensives & NSAIDS

A

NSAIDS can reduce effectiveness of Antihypertensives

Reverse effects of hypotensive drugs

both block COX-1 cox2

– which impairs prostaglandin synth

24
Q

pharmacoDYNAMIC Interactions

A

Mechanism of Action of Drugs

Acting or blocking the SAME RECEPTOR

SAME PHYSIOLOGICAL AFFECT

  • Beta-2 receptors
    • Propranolol can block effects of Salbutamol for asthma treatment
  • Muscarinic Receptors
    • Antihistamines / Antidepressants / Phenothiazines
      • –> Confusion / memory loss
    • MANY DRUGS HAVE AntiCHOLINERGIC EFFECTS
25
Q

Additive Adverse Interactions

A
  • Weak sedatives:
    • Diphenhydramine / quetiapine / mirtazapine / pregablin / gabapentin
  • _​_May not cause sedation on their own but..
    • PROFOUND SEDATION WHEN COMBINED
26
Q

How to Reduce Patient Harm

from Drug Interactions

A
  • Recognize drugs with NTI
  • recognize drugs that are major perpratrators
    • Inducers / Inhibitors
  • Applying pharmacological clinical principles
  • Elderly / Chronically ill patients
    • ​are at higher risk of DI’s
27
Q
A